Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03002311 · ClinicalTrials.gov registry record · NA
Improving Follow-Up for Discharged Emergency Care Patients
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 327
- Enrollment target
NCT03002311 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 327 participants.
The verdict
NCT03002311, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 327 participants
- Enrollment target
Study Summary
This study's purpose is to test the effects of an electronic health intervention platform developed by Epharmix (also known as CareSignal), which features two-way SMS text messages and phone calls intended to improve clinical outcomes compared to the standard of care. This was a randomized open, blinded end-point (PROBE) trial of adult patients discharged from the ED and referred to a provider for follow-up care. Participants in the intervention arm received a self-scheduling text or phone message that automatically connected them to their referral provider to schedule a follow-up appointment and sent them appointment reminders. Those in the control arm received standard of care written instructions to contact listed referral providers. The primary outcome was time to the follow-up appointment.
Interventions
- DEVICE Epharmix/CareSignal eHealth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2018-03-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03002311
The ClinicalTrials.gov registry entry for NCT03002311 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 327 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Epharmix/CareSignal eHealth is the first listed.
NCT03002311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03002311 about?
NCT03002311 is a clinical study titled "Improving Follow-Up for Discharged Emergency Care Patients". This study's purpose is to test the effects of an electronic health intervention platform developed by Epharmix (also known as CareSignal), which features two-way SMS text messages and phone calls intended to improve clinical outcomes compared to the standard of care. This was a randomized open, bli...
What is the current status of trial NCT03002311?
This trial is currently completed. It is a NA study. The enrollment target is 327 participants. The study started on 2016-01-01. Estimated completion is 2018-03-09.
What interventions are being tested in trial NCT03002311?
The interventions under investigation include: Epharmix/CareSignal eHealth (DEVICE).
Who is sponsoring clinical trial NCT03002311?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.